Lee Financial CO Novo Nordisk A S Transaction History

Lee Financial CO

  • $706 Million
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 08, 2024
BUY
$87.78 - $105.45 $8,778 - $10,545
100 Added 25.0%
500 $51,000
Q3 2023

Nov 09, 2023
BUY
$90.94 - $199.54 $18,188 - $39,908
200 Added 100.0%
400 $36,000
Q2 2023

Aug 08, 2023
BUY
$155.98 - $172.65 $31,195 - $34,530
200 New
200 $32,000

Others Institutions Holding NVO

# of Institutions
1,861
Shares Held
322M
Call Options Held
5.49M
Put Options Held
7.77M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $195B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Lee Financial CO Portfolio

Follow Lee Financial CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lee Financial CO, based on Form 13F filings with the SEC.

News

Stay updated on Lee Financial CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email